BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1679382)

  • 1. Molecular genetic considerations in osteosarcoma.
    Hansen MF
    Clin Orthop Relat Res; 1991 Sep; (270):237-46. PubMed ID: 1679382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors.
    Araki N; Uchida A; Kimura T; Yoshikawa H; Aoki Y; Ueda T; Takai S; Miki T; Ono K
    Clin Orthop Relat Res; 1991 Sep; (270):271-7. PubMed ID: 1884549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of a metastasizing testicular mixed gonadal stromal tumor with osteosarcoma components suggests that a malignant tumor with the histology of osteosarcoma may develop without primary involvement of RB1 and TP53.
    Reuvekamp PT; Stulp RP; Schraffordt Koops H; Oosterhuis JW; Scheffer H; Buys CH
    Cancer Res; 1992 Dec; 52(23):6705-7. PubMed ID: 1423318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
    Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
    Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
    Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
    Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the RB1 gene and the p53 gene in human osteosarcomas.
    Scholz RB; Kabisch H; Weber B; Röser K; Delling G; Winkler K
    Pediatr Hematol Oncol; 1992; 9(2):125-37. PubMed ID: 1524989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of RB gene in osteosarcoma by PCR].
    Li HG
    Zhonghua Wai Ke Za Zhi; 1993 Dec; 31(12):714-6. PubMed ID: 8033699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
    Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
    Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis.
    Kruzelock RP; Murphy EC; Strong LC; Naylor SL; Hansen MF
    Cancer Res; 1997 Jan; 57(1):106-9. PubMed ID: 8988049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.
    Friend SH; Bernards R; Rogelj S; Weinberg RA; Rapaport JM; Albert DM; Dryja TP
    Nature; 1986 Oct 16-22; 323(6089):643-6. PubMed ID: 2877398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of the human retinoblastoma gene.
    Lee WH; Bookstein RE; Lee EY
    Immunol Ser; 1990; 51():169-200. PubMed ID: 1965700
    [No Abstract]   [Full Text] [Related]  

  • 13. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 gene abnormalities in osteosarcoma.
    Guo W; Wang X; Feng C
    Chin Med J (Engl); 1996 Oct; 109(10):752-5. PubMed ID: 9275350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
    Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
    Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAS is amplified predominantly in surface osteosarcoma.
    Noble-Topham SE; Burrow SR; Eppert K; Kandel RA; Meltzer PS; Bell RS; Andrulis IL
    J Orthop Res; 1996 Sep; 14(5):700-5. PubMed ID: 8893761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma.
    Toguchida J; Ishizaki K; Sasaki MS; Ikenaga M; Sugimoto M; Kotoura Y; Yamamuro T
    Cancer Res; 1988 Jul; 48(14):3939-43. PubMed ID: 2898286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of transgenic mice in identification and characterization of tumour suppressor genes.
    Sharan SK; Bradley A
    Cancer Surv; 1995; 25():143-59. PubMed ID: 8718516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation status of the retinoblastoma gene (RB1) in osteosarcoma: no evidence for hypermethylation.
    Otte C; Scholz R; Werner M; Weber B; Delling G; Kabisch H
    Pediatr Hematol Oncol; 2004; 21(1):57-65. PubMed ID: 14660307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of cancer suppression by the retinoblastoma gene.
    Lee WH
    Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.